Latest News and Press Releases

The annual report for Photocure ASA (the "Company") for 2012 has previously been made available at the Company's web page: http://www.photocure.com/Investor-relations/, and is now also published on...

  This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. ...

Oslo, Norway, 22 August 2013: Photocure (OSE: PHO), a Norwegian specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, today announces its results for the...

Photocure will present its second quarter and first half 2013 report on Thursday 22 August 2013 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives...

Oslo, Norway, August 8, 2013: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announced today that Ingrid Wiik, a member...

Oslo, 23. mai 2013 Aksjene i Photocure ASA noteres eksklusiv utbytte NOK 2,00 fra og med i dag, 23.mai 2013. For ytterligere informasjon, vennligst kontakt: PhotocureFinansdirektør Erik DahlTel:...

Oslo, Norway, 23 May, 2013. The shares in Photocure ASA will be traded exclusive dividend NOK 2.00 as from today, 23 May 2013. For further information, please contact: PhotocureCFO Erik DahlTel:...

Oslo, 23. mai 2013 Ordinær generalforsamling ble avholdt i Photocure ASA den 22. mai 2013. Styret ble gjenvalgt og vil fram til neste ordinære generalforsamling bestå av følgende medlemmer: Åse...

Oslo, Norway, 23 May, 2013. The Annual General Meeting in Photocure ASA took place on 22 May, 2013. The Board of Directors was reelected and consists of the following members until next Annual...

Chairman in Photocure ASA, Åse Aulie Michelet, has as of 22 May, 2013 in addition to own shares, received proxies to vote at Photocure ASA's annual general meeting to be held on 22 May, 2013 for a...